图片来源:摄图网
近日,港股上市公司德琪医药发布公告称,与翰森制药达成独家合作协议,由翰森制药负责塞利尼索在中国大陆的商业化, 德琪医药将获最高2亿元首付款及最高5.35亿元里程碑付款。
据了解,塞利尼索是德琪医药首个上市商业化产品,从Karyopharm引进,...查看全文
不入流资讯2023-07-18 17:23
$Karyopharm(KPTI)$ Karyopharm Theraoeutics climbs 25% after securing FDA fast track designation for Selinexor for treatment of Myelofibrosis #AI_Mover#查看全文
药智网2023-08-24 15:20
来源:药智网公众号
图片来源:摄图网
近日,港股上市公司德琪医药发布公告称,与翰森制药达成独家合作协议,由翰森制药负责塞利尼索在中国大陆的商业化, 德琪医药将获最高2亿元首付款及最高5.35亿元里程碑付款。
据了解,塞利尼索是德琪医药首个上市商业化产品,从Karyopharm引进,...查看全文
$Karyopharm Therapeutics(KPTI)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2016-03-15 AccNo: 0001193125-16-505284 Size: 55 KB 网页链接
$Karyopharm Therapeutics(KPTI)$ POSASR - Post-effective Amendment to an automatic shelf registration statement Filed: 2016-03-15 AccNo: 0001193125-16-505158 Size: 343 KB 网页链接
$Karyopharm Therapeutics(KPTI)$ POS AM - Post-Effective amendments for registration statement Filed: 2016-03-15 AccNo: 0001193125-16-505239 Size: 304 KB 网页链接
$Karyopharm Therapeutics(KPTI)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2016-03-15 AccNo: 0001193125-16-505181 Size: 5 MB 网页链接
$Karyopharm Therapeutics(KPTI)$ 8-K - Current report Filed: 2016-03-14 AccNo: 0001193125-16-502309 Size: 106 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Karyopharm Therapeutics(KPTI)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-03-09 AccNo: 0001213900-16-011470 Size: 224 KB 网页链接
$Karyopharm Therapeutics(KPTI)$ 美东时间 2016-03-14 09:00 Before Open:KARYOPHARM THER Earning Release . Wall St EPS Est ($):-0.84. 网页链接
$Karyopharm Therapeutics(KPTI)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-23 AccNo: 0001213900-16-011157 Size: 227 KB 网页链接
$Karyopharm Therapeutics(KPTI)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-16 AccNo: 0001306923-16-000043 Size: 51 KB 网页链接
$Karyopharm Therapeutics(KPTI)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-12 AccNo: 0001193125-16-462320 Size: 59 KB 网页链接